Projecten per jaar
Persoonlijk profiel
Expertise
- Bone marrow and peripheral blood stem cells: biology and therapeutical use
- Stem cell processing and banking
- Tumo-host interactions in blood cancer (multiple myeloma)
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Ivan Van Riet actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
HERC44: FWO Hercules MZW: ERA platform: Extensief RNA Analyse platform
Rooman, I., Baeyens, L., Goossens, E., Vanhaecke, T., van Grunsven, L., Bouwens, L., De Bundel, D., Bautmans, I., Massie, A., Van Riet, I., De Bruyne, E., De Kock, J. & Forsyth, R.
1/05/18 → 30/04/22
Project: Fundamenteel
-
-
ANI52: Cycle for Life 2007 : Circulating endothelial cells in multiple myeloma: characterisation and study of their role as surrogate marker for myeloma-induced angiogenesis.
Vande Broek, I. & Van Riet, I.
27/09/07 → …
Project: Fundamenteel
-
FWOSB118: Tumor karakterisatie en ziekteopvolging in multipel myeloom door (epi) genetische typering gebruik makend van liquid biopsies
Heestermans, R. & Van Riet, I.
1/11/21 → 31/10/23
Project: Fundamenteel
-
ANI303: Het gebruik van vloeibare biopsieën voor MRD-detectie bij multipel myeloom
15/10/21 → 31/10/22
Project: Fundamenteel
Onderzoeksoutput
-
Validation of a PCR-based next-generation sequencing approach for the detection and quantification of minimal residual disease in acute lymphoblastic leukemia and multiple myeloma using gBlocks as calibrators
Van der Straeten, J., De Brouwer, W., Kanjinga, E. K., Dresse, M-F., Fostier, K., Schots, R., Van Riet, I. & Bakkus, M., mei 2021, In : The Journal of Molecular Diagnostics. 23, 5, blz. 599-611 13 blz.Onderzoeksoutput: Article
-
Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical Trial
Schwarze, J. K., Awada, G., Cras, L., Tijtgat, J., Forsyth, R., Dufait, I., Tuyaerts, S., Van Riet, I. & Neyns, B., dec 2020, In : Vaccines. 8, 4, blz. 1-16 16 blz., 670.Onderzoeksoutput: Article
3 Citaten (Scopus) -
A phase Ib clinical trial on intratumoral administration of autologous CD1c (BDCA-1)(+) myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and avelumab (AVE) plus intravenous low-dose nivolumab (NIVO) in patients with advanced solid tumors.
Schwarze, J. K., Awada, G., Cras, L., Forsyth, R., Van Riet, I. & Neyns, B., 20 mei 2019, In : Journal of Clinical Oncology. 37, 15, e14012.Onderzoeksoutput: Meeting abstract (Journal)
-
A phase Ib clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and avelumab (AVE) plus intravenous low-dose nivolumab (NIVO) in patients with advanced solid tumors.
Schwarze, J. K., Awada, G., Cras, L., Forsyth, R., Van Riet, I. & Neyns, B., mei 2019, Journal of Clinical Oncology. American Society of Clinical Oncology, e14012Onderzoeksoutput: Meeting abstract (Book)
-
A phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ myeloid dendritic cells plus talimogene laherparepvec (T-VEC) in patients with advanced melanoma
Schwarze, J. K., Awada, G., Cras, L., Dufait, I., Forsyth, R., Van Riet, I. & Neyns, B., 6 nov 2019, In : Journal for immunotherapy of cancer. 7, blz. unknownOnderzoeksoutput: Meeting abstract (Journal)
Activiteiten
-
29th General Annual Meeting of the Belgian Hematological Society
Ivan Van Riet (Speaker)30 jan 2014 → 31 jan 2014Activiteit: Talk or presentation at a workshop/seminar
-
15th Post-ASH meeting
Ivan Van Riet (Participant)11 jan 2013Activiteit: Participation in workshop, seminar
-
39th Annual Meeting of the European Group for Blood and Marrow Transplantation
Ivan Van Riet (Keynote speaker)7 apr 2013 → 10 apr 2013Activiteit: Talk or presentation at a conference
-
28th General Annual Meeting of the Belgian Hematological Society
Ivan Van Riet (Keynote speaker)24 jan 2013 → 26 jan 2013Activiteit: Talk or presentation at a conference
-
27th General Meeting of the Belgian Hematological Society
Ivan Van Riet (Participant)27 jan 2012 → 28 jan 2012Activiteit: Participation in workshop, seminar
Scriptie
-
AC133 (CD133) expressie in beenmerg, gemobiliseerd bloed en navelstrengbloed: een geschikte merker voor isolatie van mesenchymale stamcellen?
Auteur: Boeckx, L. & Van Riet, I., 2003Begeleider: Van Riet, I. (Promotor)
Scriptie/masterproef: Master's Thesis
-
Beta cell regeneration and normoglycemia restoration in diabetic mica through myeloid cell-driven angiogenesis
Auteur: Xiao, X., 6 jun 2011Begeleider: Heimberg, H. (Promotor), Dor, Y. (Externe persoon) (Jury), Haigh, J. (Externe persoon) (Jury), Luttun, A. (Externe persoon) (Jury), Vanderkerken, K. (Jury), Tournaye, H. (Jury), Van Riet, I. (Promotor) & Thielemans, K. (Promotor)
Scriptie/masterproef: Doctoral Thesis
-
Beta cell regeneration and normoglycemia restoration in diabetic mice through myeloid celldriven angiogenesis
Auteur: Xiao, X., Heimberg, H., Thielemans, K., Vanderkerken, K., Tournaye, H., Van Riet, I., Dor, Y., Haigh, J. & Luttun, A., 6 jun 2011Begeleider: Heimberg, H. (Promotor), Thielemans, K. (Jury), Vanderkerken, K. (Jury), Tournaye, H. (Jury), Van Riet, I. (Jury), Dor, Y. (Externe persoon) (Jury), Haigh, J. (Externe persoon) (Jury) & Luttun, A. (Externe persoon) (Jury)
Scriptie/masterproef: Doctoral Thesis
-
Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. An open gate towards endogenous stem cell therapy in diabetes.
Auteur: Xu, X., Heimberg, H., Van Schravendijk, C., Peters, E., Van Riet, I., Ferrer, J., Nielsen, F. C., Blanpain, C. & Verfaillie, C., 22 jun 2009Begeleider: Heimberg, H. (Promotor), Van Schravendijk, C. (Jury), Peters, E. (Jury), Van Riet, I. (Jury), Ferrer, J. (Externe persoon) (Jury), Nielsen, F. C. (Externe persoon) (Jury), Blanpain, C. (Externe persoon) (Jury) & Verfaillie, C. (Externe persoon) (Jury)
Scriptie/masterproef: Doctoral Thesis
-
Biological properties of mesenchymal stem cells in the multiple myeloma tumor microenvironment
Auteur: Xu, S., Van Riet, I., Vanderkerken, K., Schots, H., Heimberg, H., VandenDriessche, T., Voermans, C., Beguin, Y. & Olivier, D. W., 13 sep 2012Begeleider: Van Riet, I. (Promotor), Vanderkerken, K. (Co-promotor), Schots, H. (Jury), Heimberg, H. (Jury), Vandendriessche, T. (Jury), Voermans, C. (Externe persoon) (Jury), Beguin, Y. (Externe persoon) (Jury) & De Wever, O. (Externe persoon) (Jury)
Scriptie/masterproef: Doctoral Thesis